Company
Beta Bionics
Beta Bionics is a people-focused company dedicated to making diabetes easier for everyone, every day.
Also known as Beta Bionics, Inc., Beta Bionics®
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2015
- Legal name
- Beta Bionics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Beta Bionics is focused on the design, development, and commercialization of an automated insulin delivery system composed of our FDA-approved iLet ACE Pump, iLet Dosing Decision Software, and integrated continuous glucose monitor (collectively, “ iLet System ”).
Funding snapshot
- Total raised
- $277MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $99.5M2023-08-28
Funding rounds
- Round, 2023
- $99.5M2023-08-28, SEC form D sold, 29 investors
- Round, 2022
- $57M2022-02-16, SEC form D sold, 21 investors
- Round, 2019
- $63.4M2019-07-01, SEC form D sold, 12 investors
- Round, 2017
- $57.6M2017-12-19, SEC form D sold, 24 investors
Products
- Hardware
- iLet Bionic Pancreas
Loading relationship preview